Developmental biologyAnimalsCarcinomaPancreatic DuctalTrans-ActivatorsHomeodomain Proteins
Pharmacological approaches to understanding the role of PDX1 in pancreatic ductal adenocarcinoma: Insights from the chick CAM model.
María Jimena Mosna, Marcelo G Stinson, Federico J Garde, Candela D Pastore, Lucía P Petriz, Abel L Carcagno
Published: 202610.1016/j.ydbio.2025.10.015
Abstract
Pancreatic ductal adenocarcinoma (PDAC), the most prevalent form of pancreatic cancer, has a 5-year survival rate of 9 %. PDX1 is an important transcription factor for embryonic development of the pancreas, pancreatic endocrine lineage differentiatio…
Preview only. Read the full abstract at the source